Gary Gilmour
Director of Preclinical Research
Gary runs the preclinical research programme at COMPASS.
Gary initially studied Pharmacology at the University of Glasgow before completing a DPhil in Neuroscience at the University of Oxford. Gary has built his career in the pharmaceutical industry, most recently working for Eli Lilly as a Research Advisor in the Pain Discovery Group. Gary has led discovery and novel target projects across a broad range of neuroscience indications, and has driven the establishment of pioneering techniques establishing preclinical proxies of BOLD imaging in behavioural studies. His approaches to drug discovery place high emphasis on translational validation and establishing a deeper understanding of the biological substrates underlying different disease related symptoms.